Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment.
Alp E, Damkaci F, Guven E, Tenniswood M.
Int J Nanomedicine · research-article; journal article · DOI 10.2147/ijn.s191837 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för CG-1521. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
12 hitsBerberine acts as a putative epigenetic modulator by affecting the histone code.
Wang Z, Liu Y, Xue Y, Hu H, Ye J, Li X, Lu Z, Meng F, Liang S.
Toxicol In Vitro · journal article · DOI 10.1016/j.tiv.2016.06.004Gcn5 Modulates the Cellular Response to Oxidative Stress and Histone Deacetylase Inhibition.
Gaupel AC, Begley TJ, Tenniswood M.
J Cell Biochem · journal article · DOI 10.1002/jcb.25153High throughput screening identifies modulators of histone deacetylase inhibitors.
Gaupel AC, Begley T, Tenniswood M.
BMC Genomics · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1471-2164-15-528Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells.
Chatterjee N, Wang WL, Conklin T, Chittur S, Tenniswood M.
Cancer Biol Ther · comparative study; research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.4161/cbt.25088Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.
Knutson AK, Welsh J, Taylor T, Roy S, Wang WL, Tenniswood M.
Oncol Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/or.2011.1590Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors.
Yan C, Xiu Z, Li X, Li S, Hao C, Teng H.
Proteins · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1002/prot.22047Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.
Su H, Nebbioso A, Carafa V, Chen Y, Yang B, Altucci L, You Q.
Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2008.07.066Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells.
Roy S, Jeffrey R, Tenniswood M.
Mol Cancer Ther · research support, non-u.s. gov't; journal article · DOI 10.1158/1535-7163.mct-07-2353Site-specific acetylation of p53 directs selective transcription complex assembly.
Roy S, Tenniswood M.
J Biol Chem · research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.m609588200Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.
Roy S, Packman K, Jeffrey R, Tenniswood M.
Cell Death Differ · research support, non-u.s. gov't; journal article · DOI 10.1038/sj.cdd.4401581QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids.
Wang DF, Wiest O, Helquist P, Lan-Hargest HY, Wiech NL.
Bioorg Med Chem Lett · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1016/j.bmcl.2003.11.062